Cabaletta Bio Ownership | Who Owns Cabaletta Bio?


OverviewForecastRevenueFinancialsChart

Cabaletta Bio Ownership Summary


Cabaletta Bio is owned by 98.18% institutional investors, 3.10% insiders. Jennison associates is the largest institutional shareholder, holding 11.25% of CABA shares. Alger Small Cap Focus Composite is the top mutual fund, with 5.31% of its assets in Cabaletta Bio shares.

CABA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCabaletta Bio98.18%3.10%-1.28%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jennison associates5.55M11.25%$41.49M
Blackrock4.76M9.65%$35.58M
T. rowe price investment management3.88M7.87%$29.01M
Adage capital partners gp3.04M6.16%$22.71M
Fred alger management2.52M5.12%$18.87M
Vanguard group2.37M4.80%$17.70M
State street2.01M4.07%$15.00M
Bain capital life sciences investors1.65M3.35%$12.34M
Vr adviser1.56M3.17%$11.70M
Sofinnova investments1.22M2.48%$9.13M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bain capital life sciences investors1.65M1.35%$12.34M
Superstring capital management lp139.90K1.32%$1.05M
Vr adviser1.56M0.74%$11.70M
Commodore capital lp1.10M0.56%$8.23M
Sofinnova investments1.22M0.47%$9.13M
Integral health asset management425.00K0.30%$3.18M
Healthinvest partners ab64.32K0.29%$481.12K
Redmile group442.83K0.20%$3.31M
Corton capital31.93K0.13%$238.84K
E fund management286.42K0.12%$2.14M

Top Buyers

HolderShares% AssetsChange
Jennison associates5.55M0.03%2.12M
T. rowe price investment management3.88M0.02%1.41M
Jpmorgan chase956.69K0.00%933.03K
Sofinnova investments1.22M0.47%790.65K
Blackrock4.76M0.00%699.11K

Top Sellers

HolderShares% AssetsChange
Alkeon capital management---2.62M
State street2.01M0.00%-1.74M
Polar capital---1.25M
Cormorant asset management, lp---1.10M
Wellington management group llp158.81K0.00%-849.45K

New Positions

HolderShares% AssetsChangeValue
Panagora asset management299.80K0.01%299.80K$2.24M
Walleye capital189.96K0.00%189.96K$1.42M
Jump financial182.13K0.03%182.13K$1.36M
Two sigma advisers, lp72.50K0.00%72.50K$542.30K
Corton capital31.93K0.13%31.93K$238.84K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-7.00
Gamma investing-12.00
Eversource wealth advisors-72.00
Capital advisors-81.00
Cibc private wealth group-200.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024120-15.49%48,049,085-5.40%980.93%65-7.14%33-32.65%
Jun 30, 2024142-14.97%50,793,811-0.49%1030.96%70-21.35%492.08%
Mar 31, 202416722.79%51,041,4005.15%1030.74%895.95%4854.84%
Dec 31, 202313634.65%48,539,64418.67%1181.37%8416.67%31158.33%
Sep 30, 202310114.77%40,903,60312.25%931.08%7220.00%12-14.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Alger Small Cap Focus Composite2.59M5.31%1.07M
Alger Small Cap Focus I2.59M5.31%1.07M
T. Rowe Price Small-Cap Value2.04M4.18%499.40K
Vanguard Total Stock Mkt Idx Inv1.40M2.87%-
Jennison Health Sciences Equity1.38M2.82%-
PGIM Jennison Health Sciences Z1.38M2.82%-
Jennison SMid Cap Core Equity1.29M2.63%-
PGIM Jennison Small Company A1.29M2.63%-
iShares Russell 2000 ETF1.12M2.29%-2.51K
T. Rowe Price U.S. SC Value Eq Tr-Z1.06M2.16%385.38K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 19, 2024Binder Gwendolyn See RemarksSell$14.23K
Jan 19, 2024Binder Gwendolyn See RemarksSell$201.21K
Dec 19, 2023Binder Gwendolyn See RemarksSell$171.20K
Dec 19, 2023Binder Gwendolyn See RemarksSell$69.59K
Nov 20, 2023Binder Gwendolyn See RemarksSell$61.61K

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q1-2
2023 Q4-6
2023 Q3-6
2023 Q2-2

CABA Ownership FAQ


Who Owns Cabaletta Bio?

Cabaletta Bio shareholders are primarily institutional investors at 98.18%, followed by 3.10% insiders and -1.28% retail investors. The average institutional ownership in Cabaletta Bio's industry, Biotech Stocks , is 47.04%, which Cabaletta Bio exceeds.

Who owns the most shares of Cabaletta Bio?

Cabaletta Bio’s largest shareholders are Jennison associates (5.55M shares, 11.25%), Blackrock (4.76M shares, 9.65%), and T. rowe price investment management (3.88M shares, 7.87%). Together, they hold 28.76% of Cabaletta Bio’s total shares outstanding.

Does Blackrock own Cabaletta Bio?

Yes, BlackRock owns 9.65% of Cabaletta Bio, totaling 4.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.58M$. In the last quarter, BlackRock increased its holdings by 699.11K shares, a 17.23% change.

Who is Cabaletta Bio’s biggest shareholder by percentage of total assets invested?

Bain capital life sciences investors is Cabaletta Bio’s biggest shareholder by percentage of total assets invested, with 1.35% of its assets in 1.65M Cabaletta Bio shares, valued at 12.34M$.

Who is the top mutual fund holder of Cabaletta Bio shares?

Alger Small Cap Focus Composite is the top mutual fund holder of Cabaletta Bio shares, with 5.31% of its total shares outstanding invested in 2.59M Cabaletta Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools